Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +33.91%
#2 DogBull DogBull +31.64%
#3 Siacoin Siacoin +30.66%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Pons Pons +22.32%
#6 Cash Cat Cash Cat +20.40%
#7 MarsCoin MarsCoin +16.04%
#8 Akedo Akedo +11.11%
#9 Ontology Gas Ontology Gas +10.61%
#10 Cryptopia Cryptopia +10.24%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rank in Stocks #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Share Price
$0.87679425
Last synced: 2026-08-31
Market Cap
$407.66M
Change (1 day)
-1.88%
Change (1 year)
58.03%
Country
SE
Trade Egetis Therapeutics AB (publ) (EGTX)

Category

Healthcare
Earnings for Egetis Therapeutics AB (publ) (EGTX)
Earnings in 2026 TTM: 0
According to Egetis Therapeutics AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Egetis Therapeutics AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH